Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Abstract

1518 Background: Women (W) with BRCA mutation-associated BC are at significant risk for metachronous OC, ranging from 0.8-1.5% per year. The risk of BC after a diagnosis (Dx) of BRCA-OC is unknown. METHODS MSKCC Clinical Genetics Database was searched to identify patients (pts) with BRCA-OC participating in genetic testing and follow-up studies from 1995… (More)

Topics

Cite this paper

@article{Jhaveri2011RiskOB, title={Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience.}, author={Kinnari Jhaveri and S. Patil and Mustafa Khasraw and Jatinder J Bhatia and Zmago Stadler and Noah D. Kauff and Clifford A. Hudis and Kenneth Offit and Mark E. Robson}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 15_suppl}, pages={1518} }